EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA
- 25 October 1986
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 328 (8513), 936-939
- https://doi.org/10.1016/s0140-6736(86)90598-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Diet, Lipoproteins, and the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1985
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.JCI Insight, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJama-Journal Of The American Medical Association, 1984
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971
- RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATESThe Lancet, 1969